EC Number   |
Inhibitors |
Structure |
|---|
   3.4.23.20 | Diazoacetyl-DL-norleucine methyl ester |
i.e. DAN, active-site directed inhibitor |
   |
| 3.4.23.20 | Diazoacetyl-DL-norleucine methyl ester |
i.e. DAN, active-site directed inhibitor, inactivation, also by related compounds |
|
| 3.4.23.20 | Diazoacetylglycine ethyl ester |
in presence of Cu2+ |
|
| 3.4.23.20 | Difluorostatine- and difluorostatone-containing peptides |
- |
|
| 3.4.23.20 | EDTA |
7% residual activity at 10 mM |
|
| 3.4.23.20 | Fe3+ |
complete inhibition at 10 mM |
|
| 3.4.23.20 | iodoacetic acid |
- |
|
| 3.4.23.20 | isovaleryl-Val-statine-ethoxy |
pepstatin analogue |
|
| 3.4.23.20 | Isovaleryl-Val-Val-statyl ethyl ester |
- |
|
| 3.4.23.20 | Isovaleryl-Val-Val-statyl-Ala ethyl ester |
- |
|
